Annual Life Sciences Summit - Powering Innovation Through Investment

The Freeths Annual Life Sciences Summit will return to the Ashmolean Museum in Oxford on 21 May 2026, bringing together senior investors, industry leaders, fast growth companies and founders from across the life sciences sector.

This year’s summit will focus on Investment, exploring how capital is deployed across the UK life sciences ecosystem, what investors are really looking for, and how businesses can position themselves to secure funding, scale and succeed. The discussion will examine both the current UK investment landscape and the practical realities companies face when raising capital, from early stage funding through to growth and scale up.

We are delighted to welcome Tim Davis, Regional Head of Primary Markets at London Stock Exchange Group, Robert Sears, Chief Investment Officer at Rathbones and Jette Cowan, Head of Commercial at Reading Scientific Services Ltd as panellists, alongside John Blackwood, Vice President at Scripta Therapeutics as moderator. Together, the panel will share insights into investor decision making, market confidence, and how perception, storytelling and strategy influence where capital flows.

Why attend?

This summit is a must attend for life sciences professionals looking to better understand the investment environment, connect with investors and peers, and gain practical insight into what drives successful funding journeys. The evening will offer candid discussion, real world perspectives and valuable networking opportunities across the sector.

Join us for an engaging evening of discussion and connection, as we explore how the UK can strengthen its investment proposition and support life sciences businesses at every stage of growth.

Accessibility

We want everyone to feel welcome and take part in our event. If you have any special accessibility requirements, please get in touch with millie.skinner@freeths.co.uk